, Tracking Stock Market Picks
Enter Symbol:
Boston Scientific Corporation (BSX) [hlAlert]

Sell BSX
down 66.70 %

Boston Scientific Corporation (BSX) rated Sell with price target $4.50 by Maxim Group

Posted on: Tuesday,  Sep 21, 2010  8:25 AM ET by Maxim Group

Maxim Group rated Sell Boston Scientific Corporation (NYSE: BSX) on 09/21/2010, when the stock price was $5.64. Since
then, Boston Scientific Corporation has gained 200.35% as of 10/28/2015's recent price of $16.94.
If you would have followed this Maxim Group's recommendation on BSX, you would have lost 66.7% of your investment in 1863 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2010 8:25 AM Sell
5.64 4.50
as of 12/31/2010
1 Week up  7.01 %
1 Month down  -11.52 %
3 Months down  -16.80 %
1 YTD down  -26.95 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy